Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Applying an equity lens to pharmacogenetic research and translation to under-represented populations.

Clinical and translational science - 1 Nov 2021

Luczak Tiana, Stenehjem David, Brown Jacob

Abstract excerpt

Since the publication of the Human Genome Project, genetic information has been used as an accepted, evidence-based biomarker to optimize patient care through the delivery of precision health. Pharmacogenetics (PGx) uses information about genes that encode proteins involved in pharmacokinetics, pharmacodynamics, and hypersensitivity reactions to guide clinical decision making to optimize medication therapy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP2D6
Share to Genetic Variation
Share to Genome, Human

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics and Rare Diseases

Share to Pharmaceutical studies and practices

Share to Pharmacogenetics

Share to Pharmacogenetics and Drug Metabolism

Source

Open in PubMed Open full text

Identifiers

PMID: 34268895
DOI: 10.1111/cts.13110
PMCID: PMC8604241

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Applying an equity lens to pharmacogenetic research and translation to under-represented populations.PMID 34268895Read ↗

Diversity In Precision Medicine And Pharmacogenetics: Methodological And Conceptual Considerations For Broadening ParticipationSemantic proximity Read ↗

Relevance of pharmacogenomics for developing countries in EuropeSemantic proximity Read ↗

Pharmacogenomics in Africa: A Potential Catalyst for Precision Medicine in Genetically Diverse Populations.Semantic proximity Read ↗

One Step Ahead in Realizing Pharmacogenetics in Low- and Middle-Income Countries: What Should We Do?Semantic proximity Read ↗

Pharmacogenetics: Opportunities for the All of Us Research Program and Other Large Data Sets to Advance the FieldSemantic proximity Read ↗

Progress towards the integration of pharmacogenomics in practice.Semantic proximity Read ↗

Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting.Semantic proximity Read ↗

Development of an Ancestrally Inclusive Preemptive Pharmacogenetic Testing Panel.Semantic proximity Read ↗

Importance of genetic ancestry in pharmacogenomics for precision medicine.Semantic proximity Read ↗

Translational Pharmacogenomics: Discovery, Evidence Synthesis and Delivery of Race‐Conscious MedicineSemantic proximity Read ↗

Frequency of pharmacogenomic variation and medication exposures among All of Us ParticipantsSemantic proximity Read ↗

A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.